| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.1 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |